Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
PHE has been tasked by DHSC to urgently undertake a study to evaluate the immune response following COVID-19 vaccines as part of the National Immunisation Programme. This has been identified as a high national public health priority and a key aspect of this study requires taking 2000 samples for cellular work over a 24-month period. The UK Vaccines Taskforce have selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Aligning PHE's study with this decision will ensure that it is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Oxford Immunotec Ltd | 04516079 | £240,000 | - |
Government spending data: This supplier has received £867,227 in 51 payments (over £25k) from The Royal Wolverhampton NHS Trust, BEIS, NHS England, Ministry of Defence, Guy's and St Thomas' NHS FT (2020-02-29 to 2026-02-28). View full payment history →